1. The FOXO family of transcription factors: key molecular players in gastric cancer
   Ying Liu et al, 2022, Journal of Molecular Medicine CrossRef
2. Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429
   Xiaofeng Wang et al, 2022, Frontiers in Genetics CrossRef
3. Non-coding RNAs underlying chemoresistance in gastric cancer
   Arash Poursheikhani et al, 2020, Cellular Oncology CrossRef
4. MicroRNA‑25 promotes cell proliferation, migration and invasion in glioma by directly targeting cell adhesion molecule 2
   Gang Peng et al, 2021, Experimental and Therapeutic Medicine CrossRef
5. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
   Jens C. Hahne et al, 2018, Frontiers in Oncology CrossRef
6. Role of MicroRNAs in Cancer Drug Resistance
   Kondapalli N. Babu et al, 2022, Role of MicroRNAs in Cancers CrossRef
7. Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development
   Liying Sun et al, 2023, Frontiers in Oncology CrossRef
8. Non-coding RNA in drug resistance of gastric cancer
   Ya-Jun Luo et al, 2019, World Journal of Gastrointestinal Oncology CrossRef
9. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
   Pía Loren et al, 2022, Frontiers in Pharmacology CrossRef
10. Role of microRNAs in drug resistance of gastric cancer cells
    Bi-Bo Tan et al, 2019, World Chinese Journal of Digestology CrossRef
11. FoxO3 and oxidative stress: a multifaceted role in cellular adaptation
    Victoria Simões Bernardo et al, 2023, Journal of Molecular Medicine CrossRef